NCT04444921

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2020-11-17Est. Completion: 2027-03-31

Enrollment target: 205 participants

Locations

Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
Anchorage Radiation Therapy Center, Anchorage, Alaska, United States
Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States
Alaska Women's Cancer Care, Anchorage, Alaska, United States
Anchorage Oncology Centre, Anchorage, Alaska, United States
Katmai Oncology Group, Anchorage, Alaska, United States
Providence Alaska Medical Center, Anchorage, Alaska, United States
Kingman Regional Medical Center, Kingman, Arizona, United States
Cancer Center at Saint Joseph's, Phoenix, Arizona, United States
Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States
CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States
Kaiser Permanente-Anaheim, Anaheim, California, United States
Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States
Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California, United States

Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell CarcinomaStage IIB Anal Cancer AJCC v8Stage III Anal Cancer AJCC v8

This phase III trial investigates how well nivolumab after combined modality therapy works in treating patients with hig…

Birmingham, United StatesEst. completion Dec 31, 2027

Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Canal Squamous Cell Carcinoma

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.